ConductScience.org, home

Paper36972253

Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.

Thiesen AP and 2 others. PLoS One, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer. Papers, record 36972253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36972253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
PubMed
Journal
PLoS One
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2023-04-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thiesen APAna Paula
2Mielczarski BBruna
3Savaris RFRicardo Francalaccihttps://orcid.org/0000-0002-2779-5443

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Deep LearningMajor topic
Image Interpretation, Computer-AssistedMajor topic
Female
Humans
Biglycan
Biomarkers, Tumor
Case-Control Studies
Neural Networks, Computer

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
212153565Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts.Eur J Biochem2002https://conductscience.org/library/papers/12153565PubMed
333538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
433716731Advanced Approaches to Breast Cancer Classification and Diagnosis.Front Pharmacol2020https://conductscience.org/library/papers/33716731PubMed
524681892Biglycan enhances gastric cancer invasion by activating FAK signaling pathway.Oncotarget2014https://conductscience.org/library/papers/24681892PubMed
61968422Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively.Genomics1990https://conductscience.org/library/papers/1968422PubMed
723817524Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan.Integr Biol (Camb)2013https://conductscience.org/library/papers/23817524PubMed
832194659Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.Oncol Lett2020https://conductscience.org/library/papers/32194659PubMed
924223213Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer.PLoS One2013https://conductscience.org/library/papers/24223213PubMed
1033809543The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness.Cancers (Basel)2021https://conductscience.org/library/papers/33809543PubMed
1121719787Small leucine-rich proteoglycans in kidney disease.J Am Soc Nephrol2011https://conductscience.org/library/papers/21719787PubMed
1212131154Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists.Am J Surg Pathol2002https://conductscience.org/library/papers/12131154PubMed
1333107395A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development.Technol Cancer Res Treat2020https://conductscience.org/library/papers/33107395PubMed
1425356943Expression of elafin in fallopian tubes of ectopic pregnancies is reduced.Appl Immunohistochem Mol Morphol2015https://conductscience.org/library/papers/25356943PubMed
1522821552Biglycan: a multivalent proteoglycan providing structure and signals.J Histochem Cytochem2012https://conductscience.org/library/papers/22821552PubMed
1633966638Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.Breast Cancer Res2021https://conductscience.org/library/papers/33966638PubMed
1724341124Comparison of HSCORE assessment of endometrial beta3 integrin subunit expression with digital HSCORE using computerized image analysis (ImageJ).Anal Quant Cytopathol Histpathol2013https://conductscience.org/library/papers/24341124PubMed
182647739Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species.J Biol Chem1989https://conductscience.org/library/papers/2647739PubMed
1925927296A potential mechanism for extracellular matrix induction of breast cancer cell normality.Breast Cancer Res2014https://conductscience.org/library/papers/25927296PubMed
202212616Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues.J Histochem Cytochem1990https://conductscience.org/library/papers/2212616PubMed

See all 25 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41788706Fusion of genomic and pathological data for breast cancer detection using BCDNN.Front Med (Lausanne)2026https://conductscience.org/library/papers/41788706PubMed
39903727BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.PLoS One2025https://conductscience.org/library/papers/39903727PubMed
37509212The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.Cancers (Basel)2023https://conductscience.org/library/papers/37509212PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BGN633PubTator's text mininghttps://conductscience.org/library/genes/633NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36972253

GET https://conductscience.org/api/papers/v1/36972253/references?page=2